Anna Estival
Las Palmas De Gran Canaria, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).
Journal: Archivos de bronconeumologia
Published: January 13, 2026
Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.
Journal: Biomarker research
Published: January 09, 2026
Biomarker landscape in advanced NSCLC: insights from a national prospective registry.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 23, 2025
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines.
Journal: Cancer cell international
Published: March 13, 2025
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.
Journal: Cancer treatment and research communications
Published: November 03, 2024
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry.
Journal: Archivos de bronconeumologia
Published: May 28, 2024
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2024
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 22, 2023
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Journal: Archivos de bronconeumologia
Published: November 06, 2023
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2023
Immunogenicity of COVID-19 vaccines in lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 21, 2023
Last Updated: 09/26/2026